UBS Lux Equity Fund Biotech USD vs DNB Teknologi

UBS Lux Equity Fund Biotech USD vs DNB Teknologi

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

2. DNB Teknologi

  • Security

    DNB Teknologi A

  • Fee

    1.14%

  • ISIN

    NO0010337678

  • Holdings

    22

  • Number of owning funds

    1

Fund Holdings

We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with DNB Teknologi, we have 33 holdings where Microsoft is the largest holding (9.64), followed by Alphabet (7.17) and Meta (4.35).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and DNB Teknologi.

UBS Lux Equity Fund Biotech USD DNB Teknologi
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Microsoft Corp
USA
9.64 %
2. Moderna Inc
9.21 %
2. Alphabet Inc Class A
USA
7.17 %
3. Vertex Pharmaceuticals Inc
8.44 %
3. Meta Platforms A
USA
4.35 %
4. Alnylam Pharmaceuticals Inc
8.08 %
4. Nvidia Corp
USA
4.25 %
5. AbbVie Inc
USA
4.91 %
5. Amazon.com Inc
USA
4.1 %
6. Gilead Sciences Inc
USA
4.66 %
6. Nokia Oyj
4.1 %
7. Amgen Inc
USA
4.43 %
7. Ericsson B
Sweden
3.19 %
8. BioNTech SE
4.13 %
8. Oracle Corp
2.99 %
9. Karuna Therapeutics Inc
3.75 %
9. SAP SE
Germany
2.47 %
- 10. SK Hynix Inc
South Korea
2.35 %
- 11. Visa Inc
USA
2.28 %
- 12. Mastercard Inc
USA
2.19 %
- 13. Western Digital Technologies Inc
USA
2.19 %
- 14. Apple Inc
USA
2.06 %
- 15. Datadog Inc
USA
2.01 %
- 16. Sandisk Corp
USA
1.91 %
- 17. Lam Research Corp
USA
1.76 %
- 18. ASML Holding NV
Netherlands
1.53 %
- 19. Broadcom Inc
USA
1.48 %
- 20. Samsung Electronics Co Ltd
South Korea
1.35 %
- 21. Embracer Group B
Sweden
1.35 %
- 22. Nordic Semiconductor ASA
Norway
1.3 %

The list of fund holdings was last updated on July 25, 2025.